{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:05:17Z","timestamp":1787025917821,"version":"build-2736575974"},"reference-count":91,"publisher":"Deutscher Arzte-Verlag GmbH","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.3238\/arztebl.2019.0681","type":"journal-article","created":{"date-parts":[[2019,10,4]],"date-time":"2019-10-04T02:35:39Z","timestamp":1570156539000},"source":"Crossref","is-referenced-by-count":30,"title":["Sleep-Related Disorders in Neurology and Psychiatry"],"prefix":"10.3238","author":[{"given":"Jan","family":"R\u00e9mi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Pollm\u00e4cher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Spiegelhalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Trenkwalder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"11437","published-online":{"date-parts":[[2019,10,11]]},"reference":[{"key":"10.3238\/arztebl.2019.0681_ref1","unstructured":"American Academy of Sleep Medicine. The International Classification of Sleep Disorders \u2013 Third Edition (ICSD-3). Darien, Il, Il: American Academy of Sleep Medicine; 2014."},{"key":"10.3238\/arztebl.2019.0681_ref2","doi-asserted-by":"crossref","unstructured":"Pollm\u00e4cher T, Wetter TC, Happe S, Richter K, Acker J, Riemann D: Schlafmedizinische Differenzialdiagnostik in Psychiatrie und Psychotherapie. Nervenarzt 2014; 85: 57\u201366","DOI":"10.1007\/s00115-013-3895-4"},{"key":"10.3238\/arztebl.2019.0681_ref3","doi-asserted-by":"crossref","unstructured":"Morin CM, Drake CL, Harvey AG, et al.: Insomnia disorder. Nat Rev Dis Prim 2015; 1: 15026","DOI":"10.1038\/nrdp.2015.26"},{"key":"10.3238\/arztebl.2019.0681_ref4","doi-asserted-by":"crossref","unstructured":"Kucharczyk ER, Morgan K, Hall AP: The occupational impact of sleep quality and insomnia symptoms. Sleep Med Rev 2012; 16: 547\u201359","DOI":"10.1016\/j.smrv.2012.01.005"},{"key":"10.3238\/arztebl.2019.0681_ref5","doi-asserted-by":"crossref","unstructured":"Riemann D, Baum E, Cohrs S, et al.: S3-Leitlinie Nicht erholsamer Schlaf\/Schlafst\u00f6rungen Kapitel \u201eInsomnie bei Erwachsenen\u201c. Somnologie 2017; 21: 2\u201344","DOI":"10.1007\/s11818-016-0097-x"},{"key":"10.3238\/arztebl.2019.0681_ref6","doi-asserted-by":"crossref","unstructured":"Riemann D, Baglioni C, Bassetti C, et al.: European guideline for the diagnosis and treatment of insomnia. J Sleep Res 2017; 26: 675\u2013700","DOI":"10.1111\/jsr.12594"},{"key":"10.3238\/arztebl.2019.0681_ref7","doi-asserted-by":"crossref","unstructured":"Pollm\u00e4cher T, Wetter TC: Schlafst\u00f6rungen und psychische Erkrankungen. Stuttgart: Kohlhammer; 2017. 223 p.","DOI":"10.17433\/978-3-17-033293-5"},{"key":"10.3238\/arztebl.2019.0681_ref8","doi-asserted-by":"crossref","unstructured":"Everitt H, Baldwin DS, Stuart B, et al.: Antidepressants for insomnia in adults. Cochrane Database Syst Rev 2018; 5: CD010753","DOI":"10.1002\/14651858.CD010753.pub2"},{"key":"10.3238\/arztebl.2019.0681_ref9","doi-asserted-by":"crossref","unstructured":"R\u00f6sner S, Englbrecht C, Wehrle R, Hajak G, Soyka M: Eszopiclone for insomnia. Cochrane Database Syst Rev 2018; 10: CD010703","DOI":"10.1002\/14651858.CD010703.pub2"},{"key":"10.3238\/arztebl.2019.0681_ref10","doi-asserted-by":"crossref","unstructured":"Mayer G, Arzt M, Braumann B, et al.: S3-Leitlinie Nicht erholsamer Schlaf\/Schlafst\u00f6rungen Kapitel \u201eSchlafbezogene Atmungsst\u00f6rungen bei Erwachsenen\u201c. Somnologie 2017; 20 (Suppl s2): S97\u2013180","DOI":"10.1007\/s11818-016-0093-1"},{"key":"10.3238\/arztebl.2019.0681_ref11","doi-asserted-by":"crossref","unstructured":"DGSM: S3-Leitlinie. Somnologie \u2013 Schlafforsch und Schlafmedizin 2009; 13 (S1): 1\u2013160","DOI":"10.1007\/s11818-009-0430-8"},{"key":"10.3238\/arztebl.2019.0681_ref12","doi-asserted-by":"crossref","unstructured":"Ruoff C, Rye D: The ICSD-3 and DSM-5 guidelines for diagnosing narcolepsy: clinical relevance and practicality. Curr Med Res Opin 2016; 32: 1\u201312","DOI":"10.1080\/03007995.2016.1208643"},{"key":"10.3238\/arztebl.2019.0681_ref13","doi-asserted-by":"crossref","unstructured":"Mahoney CE, Cogswell A, Koralnik IJ, Scammell TE: The neurobiological basis of narcolepsy. Nat Rev Neurosci 2019; 20: 83\u201393","DOI":"10.1038\/s41583-018-0097-x"},{"key":"10.3238\/arztebl.2019.0681_ref14","doi-asserted-by":"crossref","unstructured":"Billiard M, Sonka K: Idiopathic hypersomnia. Sleep Med Rev 2016; 29: 23\u201333","DOI":"10.1016\/j.smrv.2015.08.007"},{"key":"10.3238\/arztebl.2019.0681_ref15","doi-asserted-by":"crossref","unstructured":"Derry CP, Davey M, Johns M, et al.: Distinguishing sleep disorders from seizures: diagnosing bumps in the night. Arch Neurol 2006; 63: 705\u20139","DOI":"10.1001\/archneur.63.5.705"},{"key":"10.3238\/arztebl.2019.0681_ref16","doi-asserted-by":"crossref","unstructured":"Stallman HM, Kohler M: Prevalence of sleepwalking: a systematic review and meta-analysis. Arez AP, editor. PLoS One 2016; 11: e0164769","DOI":"10.1371\/journal.pone.0164769"},{"key":"10.3238\/arztebl.2019.0681_ref17","doi-asserted-by":"crossref","unstructured":"Stallman HM, Kohler M, White J: Medication induced sleepwalking: a systematic review. Sleep Med Rev 2018; 37: 105\u201313","DOI":"10.1016\/j.smrv.2017.01.005"},{"key":"10.3238\/arztebl.2019.0681_ref18","doi-asserted-by":"crossref","unstructured":"Stiasny-Kolster K, Mayer G, Sch\u00e4fer S, M\u00f6ller JC, Heinzel-Gutenbrunner M, Oertel WH: The REM sleep behavior disorder screening questionnaire\u2014a new diagnostic instrument. Mov Disord 2007; 22: 2386\u201393","DOI":"10.1002\/mds.21740"},{"key":"10.3238\/arztebl.2019.0681_ref19","doi-asserted-by":"crossref","unstructured":"Schenck CH, Boeve BF, Mahowald MW: Delayed emergence of a parkinsonian disorder or dementia in 81% of older men initially diagnosed with idiopathic rapid eye movement sleep behavior disorder: a 16-year update on a previously reported series. Sleep Med 2013; 14: 744\u20138","DOI":"10.1016\/j.sleep.2012.10.009"},{"key":"10.3238\/arztebl.2019.0681_ref20","doi-asserted-by":"crossref","unstructured":"Allen RP, Picchietti D, Hening WA, et al.: Restless legs syndrome: Diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med 2003; 4: 101\u201319","DOI":"10.1016\/S1389-9457(03)00010-8"},{"key":"10.3238\/arztebl.2019.0681_ref21","doi-asserted-by":"crossref","unstructured":"Bartl M, Winkelmann J, H\u00f6gl B, Paulus W, Trenkwalder C: H\u00e4ufige neurologische Erkrankungen assoziiert mit dem Restless-legs-Syndrom. Nervenarzt. 2018; 89: 1156\u201364","DOI":"10.1007\/s00115-018-0528-y"},{"key":"10.3238\/arztebl.2019.0681_ref22","doi-asserted-by":"crossref","unstructured":"Winkelmann J, Allen RP, H\u00f6gl B, et al.: Treatment of restless legs syndrome: Evidence-based review and implications for clinical practice (Revised 2017). Mov Disord 2018; 33: 1077\u201391","DOI":"10.1002\/mds.27260"},{"key":"10.3238\/arztebl.2019.0681_ref23","doi-asserted-by":"crossref","unstructured":"Allen RP, Chen C, Garcia-Borreguero D, et al.: Comparison of pregabalin with pramipexole for restless legs syndrome. N Engl J Med 2014; 370: 621\u201331","DOI":"10.1056\/NEJMoa1303646"},{"key":"10.3238\/arztebl.2019.0681_ref24","doi-asserted-by":"crossref","unstructured":"de Oliveira CO, Carvalho LB, Carlos K, et al.: Opioids for restless legs syndrome. Cochrane Database Syst Rev 2016; 6: CD006941","DOI":"10.1002\/14651858.CD006941.pub2"},{"key":"10.3238\/arztebl.2019.0681_ref25","doi-asserted-by":"crossref","unstructured":"Buysse DJ: Insomnia. JAMA 2013; 309: 706","DOI":"10.1001\/jama.2013.193"},{"key":"10.3238\/arztebl.2019.0681_ref26","doi-asserted-by":"crossref","unstructured":"Morin CM, B\u00e9langer L, LeBlanc M, et al.: The natural history of insomnia: a population-based 3-year longitudinal study. Arch Intern Med 2009; 169: 447\u201353","DOI":"10.1001\/archinternmed.2008.610"},{"key":"10.3238\/arztebl.2019.0681_ref27","doi-asserted-by":"crossref","unstructured":"Kyle SD, Morgan K, Espie CA: Insomnia and health-related quality of life. Sleep Med Rev 2010; 14: 69\u201382","DOI":"10.1016\/j.smrv.2009.07.004"},{"key":"10.3238\/arztebl.2019.0681_ref28","doi-asserted-by":"crossref","unstructured":"Fortier-Brochu E, Beaulieu-Bonneau S, Ivers H, Morin CM: Insomnia and daytime cognitive performance: a meta-analysis. Sleep Med Rev 2012; 16: 83\u201394","DOI":"10.1016\/j.smrv.2011.03.008"},{"key":"10.3238\/arztebl.2019.0681_ref29","doi-asserted-by":"crossref","unstructured":"Li M, Zhang X-W, Hou W-S, Tang Z-Y: Insomnia and risk of cardiovascular disease: a meta-analysis of cohort studies. Int J Cardiol 2014; 176: 1044\u20137","DOI":"10.1016\/j.ijcard.2014.07.284"},{"key":"10.3238\/arztebl.2019.0681_ref30","doi-asserted-by":"crossref","unstructured":"Anothaisintawee T, Reutrakul S, Van Cauter E, Thakkinstian A: Sleep disturbances compared to traditional risk factors for diabetes development: Systematic review and meta-analysis. Sleep Med Rev 2016; 30: 11\u201324","DOI":"10.1016\/j.smrv.2015.10.002"},{"key":"10.3238\/arztebl.2019.0681_ref31","doi-asserted-by":"crossref","unstructured":"Baglioni C, Battagliese G, Feige B, et al.: Insomnia as a predictor of depression: a meta-analytic evaluation of longitudinal epidemiological studies. J Affect Disord 2011; 135: 10\u20139","DOI":"10.1016\/j.jad.2011.01.011"},{"key":"10.3238\/arztebl.2019.0681_ref32","doi-asserted-by":"crossref","unstructured":"Pigeon WR, Pinquart M, Conner K: Meta-analysis of sleep disturbance and suicidal thoughts and behaviors. J Clin Psychiatry 2012; 73: e1160\u20137","DOI":"10.4088\/JCP.11r07586"},{"key":"10.3238\/arztebl.2019.0681_ref33","doi-asserted-by":"crossref","unstructured":"Shi L, Chen S-J, Ma M-Y, et al.: Sleep disturbances increase the risk of dementia: a systematic review and meta-analysis. Sleep Med Rev 2018; 40: 4\u201316","DOI":"10.1016\/j.smrv.2017.06.010"},{"key":"10.3238\/arztebl.2019.0681_ref34","unstructured":"Morphy H, Dunn KM, Lewis M, Boardman HF, Croft PR: Epidemiology of insomnia: a longitudinal study in a UK population. Sleep 2007; 30: 274\u201380."},{"key":"10.3238\/arztebl.2019.0681_ref35","doi-asserted-by":"crossref","unstructured":"Weissman MM, Greenwald S, Ni\u00f1o-Murcia G, Dement WC: The morbidity of insomnia uncomplicated by psychiatric disorders. Gen Hosp Psychiatry 1997; 19: 245\u201350","DOI":"10.1016\/S0163-8343(97)00056-X"},{"key":"10.3238\/arztebl.2019.0681_ref36","doi-asserted-by":"crossref","unstructured":"Qaseem A, Kansagara D, Forciea MA, Cooke M, Denberg TD: Clinical Guidelines Committee of the American College of Physicians. Management of chronic insomnia disorder in adults: a clinical practice guideline from the American College of Physicians. Ann Intern Med 2016; 165: 125\u201333","DOI":"10.7326\/M15-2175"},{"key":"10.3238\/arztebl.2019.0681_ref37","doi-asserted-by":"crossref","unstructured":"van Straten A, van der Zweerde T, Kleiboer A, Cuijpers P, Morin C, Lancee J: Cognitive and behavioral therapies in the treatment of insomnia: a meta-analysis. Sleep 2018; 38: 3\u201316","DOI":"10.1016\/j.smrv.2017.02.001"},{"key":"10.3238\/arztebl.2019.0681_ref38","doi-asserted-by":"crossref","unstructured":"Nissen C, Frase L, Hajak G, Wetter TC: Hypnotika \u2013 Stand der Forschung. Nervenarzt. 2014; 85: 67\u201376","DOI":"10.1007\/s00115-013-3893-6"},{"key":"10.3238\/arztebl.2019.0681_ref39","doi-asserted-by":"crossref","unstructured":"Ho FYY, Chan CS, Tang KNS: Cognitive-behavioral therapy for sleep disturbances in treating posttraumatic stress disorder symptoms: a meta-analysis of randomized controlled trials. Clin Psychol Rev 2016; 43: 90\u2013102","DOI":"10.1016\/j.cpr.2015.09.005"},{"key":"10.3238\/arztebl.2019.0681_ref40","doi-asserted-by":"crossref","unstructured":"Johnson JA, Rash JA, Campbell TS, et al.: A systematic review and meta-analysis of randomized controlled trials of cognitive behavior therapy for insomnia (CBT-I) in cancer survivors. Sleep Med Rev 2016; 27: 20\u20138","DOI":"10.1016\/j.smrv.2015.07.001"},{"key":"10.3238\/arztebl.2019.0681_ref41","doi-asserted-by":"crossref","unstructured":"Tang NKY, Lereya ST, Boulton H, Miller MA, Wolke D, Cappuccio FP: Nonpharmacological treatments of insomnia for long-term painful conditions: a systematic review and meta-analysis of patient-reported outcomes in randomized controlled trials. Sleep 2015; 38: 1751\u201364","DOI":"10.5665\/sleep.5158"},{"key":"10.3238\/arztebl.2019.0681_ref42","doi-asserted-by":"crossref","unstructured":"R\u00f6sner S, Englbrecht C, Wehrle R, Hajak G, Soyka M: Eszopiclone for insomnia. Cochrane Database Syst Rev 2018; 10: CD010703","DOI":"10.1002\/14651858.CD010703.pub2"},{"key":"10.3238\/arztebl.2019.0681_ref43","doi-asserted-by":"crossref","unstructured":"Auld F, Maschauer EL, Morrison I, Skene DJ, Riha RL: Evidence for the efficacy of melatonin in the treatment of primary adult sleep disorders. Sleep Med Rev 2017; 34: 10\u201322","DOI":"10.1016\/j.smrv.2016.06.005"},{"key":"10.3238\/arztebl.2019.0681_ref44","doi-asserted-by":"crossref","unstructured":"Winokur A, DeMartinis NA, McNally DP, Gary EM, Cormier JL, Gary KA: Comparative effects of mirtazapine and fluoxetine on sleep physiology measures in patients with major depression and insomnia. J Clin Psychiatry 2003; 64: 1224\u20139","DOI":"10.4088\/JCP.v64n1013"},{"key":"10.3238\/arztebl.2019.0681_ref45","doi-asserted-by":"crossref","unstructured":"Karsten J, Hagenauw LA, Kamphuis J, Lancel M: Low doses of mirtazapine or quetiapine for transient insomnia: a randomised, double-blind, cross-over, placebo-controlled trial. J Psychopharmacol 2017; 31: 327\u201337","DOI":"10.1177\/0269881116681399"},{"key":"10.3238\/arztebl.2019.0681_ref46","doi-asserted-by":"crossref","unstructured":"Hajak G, Rodenbeck A, Voderholzer U, et al.: Doxepin in the treatment of primary insomnia: a placebo-controlled, double-blind, polysomnographic study. J Clin Psychiatry 2001; 62: 453\u201363","DOI":"10.4088\/JCP.v62n0609"},{"key":"10.3238\/arztebl.2019.0681_ref47","doi-asserted-by":"crossref","unstructured":"Krystal AD, Durrence HH, Scharf M, et al.: Efficacy and safety of Doxepin 1 mg and 3 mg in a 12-week sleep laboratory and outpatient trial of elderly subjects with chronic primary insomnia. Sleep 2010; 33: 1553\u201361","DOI":"10.1093\/sleep\/33.11.1553"},{"key":"10.3238\/arztebl.2019.0681_ref48","doi-asserted-by":"crossref","unstructured":"Riemann D, Voderholzer U, Cohrs S, et al.: Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study. Pharmacopsychiatry 2002; 35: 165\u201374","DOI":"10.1055\/s-2002-34119"},{"key":"10.3238\/arztebl.2019.0681_ref49","unstructured":"Statistisches Bundesamt. Mikrozensus 2017. www.destatis.de (last accessed on 9 April 2019)"},{"key":"10.3238\/arztebl.2019.0681_ref50","doi-asserted-by":"crossref","unstructured":"Reid KJ, Abbott SM: Jet lag and shift work disorder. Sleep Med Clin 2015; 10: 523\u201335","DOI":"10.1016\/j.jsmc.2015.08.006"},{"key":"10.3238\/arztebl.2019.0681_ref51","doi-asserted-by":"crossref","unstructured":"Morgenthaler TI, Lee-Chiong T, Alessi C, et al.: Practice parameters for the clinical evaluation and treatment of circadian rhythm sleep disorders. An american academy of sleep medicine report. Sleep 2007; 30: 1445\u201359","DOI":"10.1093\/sleep\/30.11.1445"},{"key":"10.3238\/arztebl.2019.0681_ref52","doi-asserted-by":"crossref","unstructured":"Emens JS, Laurie AL, Songer JB, Lewy AJ: Non-24-hour disorder in blind individuals revisited: variability and the influence of environmental time cues. Sleep 2013; 36: 1091\u2013100","DOI":"10.5665\/sleep.2818"},{"key":"10.3238\/arztebl.2019.0681_ref53","doi-asserted-by":"crossref","unstructured":"Emens JS, Eastman CI: Diagnosis and treatment of non-24-h sleep-wake disorder in the blind. Drugs 2017; 77: 637\u201350","DOI":"10.1007\/s40265-017-0707-3"},{"key":"10.3238\/arztebl.2019.0681_ref54","doi-asserted-by":"crossref","unstructured":"Li T, Jiang S, Han M, et al.: Exogenous melatonin as a treatment for secondary sleep disorders: a systematic review and meta-analysis. Front Neuroendocrinol 2018; 52: 22\u20138","DOI":"10.1016\/j.yfrne.2018.06.004"},{"key":"10.3238\/arztebl.2019.0681_ref55","doi-asserted-by":"crossref","unstructured":"Quera Salva MA, Hartley S, L\u00e9ger D, Dauvilliers YA: Non-24-hour sleep\u2013wake rhythm disorder in the totally blind: diagnosis and management. Front Neurol 2017; 8: 686","DOI":"10.3389\/fneur.2017.00686"},{"key":"10.3238\/arztebl.2019.0681_ref56","doi-asserted-by":"crossref","unstructured":"Keating GM: Tasimelteon: a review in non-24-hour sleep-wake disorder in totally blind individuals. CNS Drugs 2016; 30: 461\u20138","DOI":"10.1007\/s40263-016-0330-y"},{"key":"10.3238\/arztebl.2019.0681_ref57","doi-asserted-by":"crossref","unstructured":"Lockley SW, Dressman MA, Licamele L, et al.: Tasimelteon for non-24-hour sleep-wake disorder in totally blind people (SET and RESET): two multicentre, randomised, double-masked, placebo-controlled phase 3 trials. Lancet 2015; 386: 1754\u201364","DOI":"10.1016\/S0140-6736(15)60031-9"},{"key":"10.3238\/arztebl.2019.0681_ref58","doi-asserted-by":"crossref","unstructured":"Johns MW: A new method for measuring daytime sleepiness: the Epworth sleepiness scale. Sleep 1991; 14: 540\u20135","DOI":"10.1093\/sleep\/14.6.540"},{"key":"10.3238\/arztebl.2019.0681_ref59","doi-asserted-by":"crossref","unstructured":"Khatami R, Luca G, Baumann CR, et al.: The European Narcolepsy Network (EU-NN) database. J Sleep Res 2016; 25: 356\u201364","DOI":"10.1111\/jsr.12374"},{"key":"10.3238\/arztebl.2019.0681_ref60","doi-asserted-by":"crossref","unstructured":"Coelho FMS, Pradella-Hallinan M, Predazzoli Neto M, Bittencourt LRA, Tufik S: Prevalence of the HLA-DQB1*0602 allele in narcolepsy and idiopathic hypersomnia patients seen at a sleep disorders outpatient unit in S\u00e3o Paulo. Rev Bras Psiquiatr 2009; 31:10\u20134","DOI":"10.1590\/S1516-44462009000100004"},{"key":"10.3238\/arztebl.2019.0681_ref61","doi-asserted-by":"crossref","unstructured":"Liblau RS, Vassalli A, Seifinejad A, Tafti M: Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Lancet Neurol 2015; 14: 318\u201328","DOI":"10.1016\/S1474-4422(14)70218-2"},{"key":"10.3238\/arztebl.2019.0681_ref62","doi-asserted-by":"crossref","unstructured":"Murer T, Imbach LL, Hackius M, et al.: Optimizing MSLT specificity in narcolepsy with cataplexy. Sleep. 2017; 40 (12)","DOI":"10.1093\/sleep\/zsx173"},{"key":"10.3238\/arztebl.2019.0681_ref63","doi-asserted-by":"crossref","unstructured":"Kritikou I, Vgontzas AN, Rapp MA, Bixler EO: Anti-Ma1\u2013 and Anti-Ma2-associated encephalitis manifesting with rapid eye movement sleep disorder and narcolepsy with cataplexy: a case report. Biol Psychiatry 2018; 83: e39\u201340","DOI":"10.1016\/j.biopsych.2016.12.014"},{"key":"10.3238\/arztebl.2019.0681_ref64","doi-asserted-by":"crossref","unstructured":"Billiard M, Bassetti C, Dauvilliers Y, et al.: EFNS guidelines on management of narcolepsy. Eur J Neurol 2006; 13: 1035\u201348","DOI":"10.1111\/j.1468-1331.2006.01473.x"},{"key":"10.3238\/arztebl.2019.0681_ref65","doi-asserted-by":"crossref","unstructured":"US Narcolepsy Multicentre Study: Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy. US Modafinil in Narcolepsy Multicenter Study Group. Ann Neurol 1998; 43: 88\u201397","DOI":"10.1002\/ana.410430115"},{"key":"10.3238\/arztebl.2019.0681_ref66","doi-asserted-by":"crossref","unstructured":"Kollb-Sielecka M, Demolis P, Emmerich J, Markey G, Salmonson T, Haas M: The European Medicines Agency review of pitolisant for treatment of narcolepsy: summary of the scientific assessment by the Committee for Medicinal Products for Human Use. Sleep Med 2017; 33: 125\u20139","DOI":"10.1016\/j.sleep.2017.01.002"},{"key":"10.3238\/arztebl.2019.0681_ref67","unstructured":"The U.S. Xyrem Multicenter Study Group: A randomized, double-blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 2002; 25: 42\u20139."},{"key":"10.3238\/arztebl.2019.0681_ref68","doi-asserted-by":"crossref","unstructured":"Schachter M, Parkes JD: Fluvoxamine and clomipramine in the treatment of cataplexy. J Neurol Neurosurg Psychiatry 1980; 43: 171\u20134","DOI":"10.1136\/jnnp.43.2.171"},{"key":"10.3238\/arztebl.2019.0681_ref69","unstructured":"Smith M, Parkes J, Dahlitz M: Venlafaxine in the treatment of the narcoleptic syndrome. J Sleep Res 1996; 5: 217."},{"key":"10.3238\/arztebl.2019.0681_ref70","doi-asserted-by":"crossref","unstructured":"Mayer G, Benes H, Young P, Bitterlich M, Rodenbeck A: Modafinil in the treatment of idiopathic hypersomnia without long sleep time\u2014a randomized, double-blind, placebo-controlled study. J Sleep Res 2015; 24: 74\u201381","DOI":"10.1111\/jsr.12201"},{"key":"10.3238\/arztebl.2019.0681_ref71","doi-asserted-by":"crossref","unstructured":"Stubbs B, Vancampfort D, Veronese N, et al.: The prevalence and predictors of obstructive sleep apnea in major depressive disorder, bipolar disorder and schizophrenia: a systematic review and meta-analysis. J Affect Disord 2016; 197: 259\u201367","DOI":"10.1016\/j.jad.2016.02.060"},{"key":"10.3238\/arztebl.2019.0681_ref72","doi-asserted-by":"crossref","unstructured":"Guichard K, Marti-Soler H, Micoulaud-Franchi JA, et al.: The NoSAS score: a new and simple screening tool for obstructive sleep apnea syndrome in depressive disorder. J Affect Disord 2017; 227: 136\u201340","DOI":"10.1016\/j.jad.2017.10.015"},{"key":"10.3238\/arztebl.2019.0681_ref73","doi-asserted-by":"crossref","unstructured":"Hermann DM, Bassetti CL: Role of sleep-disordered breathing and sleep-wake disturbances for stroke and stroke recovery. Neurology 2016; 87: 1407\u201316","DOI":"10.1212\/WNL.0000000000003037"},{"key":"10.3238\/arztebl.2019.0681_ref74","doi-asserted-by":"crossref","unstructured":"Sahlin C, Sandberg O, Gustafson Y, et al.: Obstructive sleep apnea is a risk factor for death in patients with stroke. Arch Intern Med 2008; 168: 297","DOI":"10.1001\/archinternmed.2007.70"},{"key":"10.3238\/arztebl.2019.0681_ref75","doi-asserted-by":"crossref","unstructured":"Gorenek (chair) B, Pelliccia (co-chair) A, Benjamin EJ, et al.: European Heart Rhythm Association (EHRA)\/European Association of Cardiovascular Prevention and Rehabilitation (EACPR) position paper on how to prevent atrial fibrillation endorsed by the Heart Rhythm Society (HRS) and Asia Pacific Heart Rhythm Society. Eur J Prev Cardiol 2017; 24: 4\u201340","DOI":"10.1177\/2047487316676037"},{"key":"10.3238\/arztebl.2019.0681_ref76","doi-asserted-by":"crossref","unstructured":"Chihorek AM, Abou-Khalil B, Malow BA: Obstructive sleep apnea is associated with seizure occurrence in older adults with epilepsy. Neurology 2007; 69: 1823\u20137","DOI":"10.1212\/01.wnl.0000279334.78298.d5"},{"key":"10.3238\/arztebl.2019.0681_ref77","doi-asserted-by":"crossref","unstructured":"Petit D, Pennestri M-H, Paquet J, et al.: Childhood sleepwalking and sleep terrors. JAMA Pediatr 2015; 169: 653","DOI":"10.1001\/jamapediatrics.2015.127"},{"key":"10.3238\/arztebl.2019.0681_ref78","doi-asserted-by":"crossref","unstructured":"Schenck CH, Boyd JL, Mahowald MW: A parasomnia overlap disorder involving sleepwalking, sleep terrors, and REM sleep behavior disorder in 33 polysomnographically confirmed cases. Sleep 1997; 20: 972\u201381","DOI":"10.1093\/sleep\/20.11.972"},{"key":"10.3238\/arztebl.2019.0681_ref79","doi-asserted-by":"crossref","unstructured":"Hwang T-J, Ni H-C, Chen H-C, Lin Y-T, Liao S-C: Risk predictors for hypnosedative-related complex sleep behaviors: a retrospective, cross-sectional pilot study. J Clin Psychiatry 2010; 71: 1331\u20135","DOI":"10.4088\/JCP.09m05083bro"},{"key":"10.3238\/arztebl.2019.0681_ref80","doi-asserted-by":"crossref","unstructured":"Hoque R, Chesson AL: Zolpidem-induced sleepwalking, sleep related eating disorder, and sleep-driving: fluorine-18-flourodeoxyglucose positron emission tomography analysis, and a literature review of other unexpected clinical effects of zolpidem. J Clin Sleep Med 2009; 5: 471\u20136.","DOI":"10.5664\/jcsm.27605"},{"key":"10.3238\/arztebl.2019.0681_ref81","doi-asserted-by":"crossref","unstructured":"Halsband C, Zapf A, Sixel-D\u00f6ring F, Trenkwalder C, Mollenhauer B: The REM sleep behavior disorder screening questionnaire is not valid in de novo parkinson\u2019s disease. Mov Disord Clin Pract 2018; 5: 171\u20136","DOI":"10.1002\/mdc3.12591"},{"key":"10.3238\/arztebl.2019.0681_ref82","doi-asserted-by":"crossref","unstructured":"Iranzo A, Molinuevo JL, Santamaria J, et al.: Rapid-eye-movement sleep behaviour disorder as an early marker for a neurodegenerative disorder: a descriptive study. Lancet Neurol 2006; 5: 572\u20137","DOI":"10.1016\/S1474-4422(06)70476-8"},{"key":"10.3238\/arztebl.2019.0681_ref83","doi-asserted-by":"crossref","unstructured":"Iranzo A, Santamar\u00eda J, Valldeoriola F, et al.: Dopamine transporter imaging deficit predicts early transition to synucleinopathy in idiopathic rapid eye movement sleep behavior disorder. Ann Neurol 2017; 82: 419\u201328","DOI":"10.1002\/ana.25026"},{"key":"10.3238\/arztebl.2019.0681_ref84","doi-asserted-by":"crossref","unstructured":"Berger K, Luedemann J, Trenkwalder C, John U, Kessler C: Sex and the risk of restless legs syndrome in the general population. Arch Intern Med 2004; 164: 196\u2013202","DOI":"10.1001\/archinte.164.2.196"},{"key":"10.3238\/arztebl.2019.0681_ref85","doi-asserted-by":"crossref","unstructured":"Happe S, Vennemann M, Evers S, Berger K: Treatment wish of individuals with known and unknown restless legs syndrome in the community. J Neurol 2008; 255: 1365\u201371","DOI":"10.1007\/s00415-008-0922-7"},{"key":"10.3238\/arztebl.2019.0681_ref86","doi-asserted-by":"crossref","unstructured":"Szentkir\u00e1lyi A, V\u00f6lzke H, Hoffmann W, Trenkwalder C, Berger K: Multimorbidity and the risk of restless legs syndrome in 2 prospective cohort studies. Neurology 2014; 82: 2026\u201333","DOI":"10.1212\/WNL.0000000000000470"},{"key":"10.3238\/arztebl.2019.0681_ref87","doi-asserted-by":"crossref","unstructured":"Trenkwalder C, Allen R, H\u00f6gl B, Paulus W, Winkelmann J: Restless legs syndrome associated with major diseases: a systematic review and new concept. Neurology 2016; 86: 1336\u201343","DOI":"10.1212\/WNL.0000000000002542"},{"key":"10.3238\/arztebl.2019.0681_ref88","doi-asserted-by":"crossref","unstructured":"Kolla BP, Mansukhani MP, Bostwick JM: The influence of antidepressants on restless legs syndrome and periodic limb movements: a systematic review. Sleep Med Rev 2018; 38: 131\u201340","DOI":"10.1016\/j.smrv.2017.06.002"},{"key":"10.3238\/arztebl.2019.0681_ref89","doi-asserted-by":"crossref","unstructured":"Trenkwalder C, Allen R, H\u00f6gl B, et al.: Comorbidities, treatment, and pathophysiology in restless legs syndrome. Lancet Neurol 2018; 17: 994\u20131005","DOI":"10.1016\/S1474-4422(18)30311-9"},{"key":"10.3238\/arztebl.2019.0681_ref90","doi-asserted-by":"crossref","unstructured":"Trotti LM, Bhadriraju S, Becker LA: Iron for restless legs syndrome. Cochrane Database Syst Rev 2012; 5: CD007834","DOI":"10.1002\/14651858.CD007834.pub2"},{"key":"10.3238\/arztebl.2019.0681_ref91","doi-asserted-by":"crossref","unstructured":"Walters AS, Wagner ML, Hening WA, et al.: Successful treatment of the idiopathic restless legs syndrome in a randomized double-blind trial of oxycodone versus placebo. Sleep 1993; 16: 327\u201332","DOI":"10.1093\/sleep\/16.4.327"}],"container-title":["Deutsches \u00c4rzteblatt international"],"original-title":[],"link":[{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2019.0681","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,21]],"date-time":"2023-09-21T03:51:28Z","timestamp":1695268288000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aerzteblatt.de\/10.3238\/arztebl.2019.0681"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,11]]},"references-count":91,"URL":"https:\/\/doi.org\/10.3238\/arztebl.2019.0681","relation":{},"ISSN":["1866-0452"],"issn-type":[{"value":"1866-0452","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,10,11]]}}}